Valued at $71.5M at its later-stage round, Jun 2025. Nothing has traded since.
- ·The complete investor list: 24 names
- ·Watch Parallel Bio: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Parallel Bio funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC (Series A1) | $20.0M | ▮ | ▮ |
| Dec 2022 | Seed Round | $4.3M | ▮ | ▮ |
Membership and data by Private Market View
Parallel Bio valuation
Parallel Bio was valued at $71.5 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Parallel Bio raised?
Parallel Bio has raised $24.6 million across 2 recorded rounds since 2022. The largest was a $4.3 million seed round in Dec 2022; the most recent was a $20 million Series A1 in Jun 2025.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Hyku Biosciences ($85 million), Linnaeus Therapeutics ($83.1 million) and Pangea Bio ($80 million).
How Parallel Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Parallel Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Parallel Bio
- What is Parallel Bio worth?
- Parallel Bio is valued at $71.5M as of Oct 2026. Valued at $71.5M at its later-stage round, Jun 2025. Nothing has traded since.
- How much has Parallel Bio raised?
- Parallel Bio has raised $24.6M in total funding across 2 recorded rounds.
- When did Parallel Bio last raise?
- Parallel Bio last raised in Jun 2025 (Later Stage VC (Series A1)), raising $20.0M.